HHS will delay the implementation of its conscience protection rule to at least November 22; Missouri's only abortion clinic can continue to provide the service through August; CMS is seeking part of Oklahma's $270 million settlement with Purdue Pharma.
The Trump administration has agreed to delay the implementation of its conscience protection rule that would allow healthcare workers to refuse to provide certain services if the service violates their religious or moral beliefs. According to The Hill, the rule, which was originally slated to be implemented July 22, will not be implemented until November 22 at the earliest. The delay is a result of an ongoing lawsuit filed in May from a coalition of Democratic-led states, which said the policy is unconstitutional.
Missouri’s only abortion clinic will be able to continue providing abortions through at least August following a ruling from the Administrative Hearing Commission, which said there’s a likelihood the clinic will win the dispute. Last week, the state health department refused to renew the clinic’s license, but a judge issued a court order that allowed the clinic to continue the service through Friday. The Associated Press reported that the Administrative Hearing Commission scheduled a hearing for August 1 on whether the state was right to not renew the license.
Following Oklahoma’s settlement with Purdue Pharma, CMS sent a letter to the director of the Oklahoma Medicaid program arguing that the federal government is entitled to a portion of the $270 million, according to the Washington Examiner. The letter did not specify how much the agency was seeking, but it did allege that Oklahoma is in violation of the Medication Program Integrity Act. However, Oklahoma State Representative Mark McBride, R-Moore, said the funds should stay within the state’s borders.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More